Skip to main content

Table 2 Physical Activity Baseline and Follow-up in Both Study Groups

From: “Randomized trial of physical activity on quality of life and lung cancer biomarkers in patients with advanced stage lung cancer: a pilot study”

  Intervention Group
(n = 20)
Usual Care Group
(n = 20)
Total
(N = 40)
P-value
Self-Reported Physical Activity (minutes)
Baseline weekly exercise minutes (moderate + vigorous)
  Mean (SD) 37.0 (46.4) 58.8 (55.8) 47.9 (51.8) 0.25
  Median (Range) 8 (0–125) 60 (0–140) 30 (0–140)
Weekly exercise minutes (moderate + vigorous) at study completion  
  Mean (SD) 160.1 (231.2) 92.6 (124.4) 127.2 (187.7) 0.52
  Median (Range) 43 (0–861) 0 (0–330) 15 (0–861)
Change between Week 1 and Week 12  
  Mean (SD) 123.01 (212.0) 34.7 (102.7) 80 (171.6) 0.051a
  Median 8 (−60–811) 0 (− 120–225) 0 (−120–811)
Step Counts
  Average step count, baseline, (range, n = 19) (week 1) 4707 (1568-12,222) N/A N/A  
  Average step count, midway (range, n = 18) (week 6) 5605 (1079-9764)    0.16
  Mean change (midway vs baseline, n = 18; range) 893 (− 5139–4874)    
  Average step count, last week (range) 4606 (746–10,238)    0.87
  Mean change (baseline vs last week; range) −107 (− 6495-4163)    
  1. ap-value is calculated in linear model controlling patient gender and baseline exercise minutes